MLN4924, an investigational NEDD8-activating enzyme (NAE) inhibitor, in patients (pts) with advanced solid tumors: Phase I study of multiple treatment schedules.
J. S. Kauh
No relevant relationships to disclose
G. Shapiro
No relevant relationships to disclose
R. B. Cohen
Consultant or Advisory Role - Millennium
Research Funding - Millennium
J. W. Clark
No relevant relationships to disclose
R. D. Harvey
No relevant relationships to disclose
J. M. Cleary
No relevant relationships to disclose
D. Mahalingam
No relevant relationships to disclose
S. Kuan
Employment or Leadership Position - Millennium
Stock Ownership - Millennium
A. McDonald
Employment or Leadership Position - Millennium
A. Berger
Employment or Leadership Position - Millennium
B. Dezube
Employment or Leadership Position - Millennium
Stock Ownership - Millennium
J. Sarantopoulos
No relevant relationships to disclose